Stock listing
NASDAQ:PBLS Parabilis Medicines, Inc. Stock
Home listing (NASDAQ) of Parabilis Medicines, Inc.
Follow Parabilis Medicines, Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:PBLS
$28.32 USD -0.38 (-1.3%)
Close on Oct 30, 2026
- Day range
- $27.48 – $28.74 USDOct 30, 2026
- Volume
- 813,911 sharesOct 30, 2026
- Market cap
- $3.45B USDAt the close on Oct 30, 2026 · price × 122.0M shares outstanding
- Traded on an average day
- $29.06M USDMedian day 605,750 shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:PBLS · Home | $28.32 USD | -0.38 (-1.3%) | 813,911 | $28.59 | $28.74 | $27.48 | $28.70 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · NASDAQ:PBLS · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $28.32 | -0.38 | -1.3% | $28.59 | $28.74 | $27.48 | 813,911 | |
| $28.70 | +0.53 | +1.9% | $28.32 | $30.08 | $27.19 | 844,724 | |
| $28.17 | +1.66 | +6.3% | $26.24 | $28.29 | $26.14 | 1,396,094 | |
| $26.51 | +1.48 | +5.9% | $25.00 | $27.20 | $24.75 | 1,572,596 | |
| $25.03 | +0.59 | +2.4% | $25.01 | $25.59 | $23.06 | 1,427,693 | |
| $24.44 | -2.48 | -9.2% | $26.74 | $26.74 | $23.96 | 1,820,900 | |
| $26.92 | -0.93 | -3.3% | $28.03 | $28.29 | $26.58 | 911,900 | |
| $27.85 | +0.77 | +2.8% | $27.39 | $28.48 | $26.40 | 1,392,000 | |
| $27.08 | +1.73 | +6.8% | $25.40 | $27.93 | $24.44 | 1,495,400 | |
| $25.35 | +2.60 | +11.4% | $22.98 | $26.24 | $22.98 | 2,142,600 | |
| $22.75 | -2.43 | -9.7% | $25.39 | $25.71 | $22.66 | 1,115,100 | |
| $25.18 | -0.71 | -2.7% | $25.76 | $26.44 | $24.80 | 955,200 | |
| $25.89 | -0.96 | -3.6% | $27.00 | $27.39 | $25.73 | 764,900 | |
| $26.85 | -2.10 | -7.3% | $29.45 | $29.50 | $26.72 | 1,187,800 | |
| $28.95 | +1.47 | +5.3% | $27.38 | $29.50 | $26.83 | 1,203,000 | |
| $27.48 | -0.61 | -2.2% | $28.15 | $29.50 | $27.21 | 1,086,600 | |
| $28.09 | -0.73 | -2.5% | $28.42 | $28.90 | $26.14 | 1,392,600 | |
| $28.82 | -0.04 | -0.1% | $28.78 | $30.36 | $27.56 | 994,000 | |
| $28.86 | -0.67 | -2.3% | $29.44 | $29.73 | $28.17 | 979,200 | |
| $29.53 | -0.75 | -2.5% | $30.41 | $30.82 | $28.56 | 572,500 | |
| $30.28 | -0.16 | -0.5% | $30.34 | $30.63 | $28.30 | 881,200 | |
| $30.44 | -1.85 | -5.7% | $31.99 | $32.63 | $29.71 | 885,800 | |
| $32.29 | +0.38 | +1.2% | $31.95 | $32.86 | $31.20 | 547,100 | |
| $31.91 | -0.66 | -2.0% | $32.84 | $33.74 | $31.20 | 453,900 | |
| $32.57 | +1.37 | +4.4% | $31.02 | $33.76 | $30.17 | 809,600 | |
| $31.20 | -1.27 | -3.9% | $32.32 | $32.32 | $29.57 | 1,119,000 | |
| $32.47 | -0.84 | -2.5% | $33.32 | $33.73 | $31.06 | 1,165,900 | |
| $33.31 | -4.86 | -12.7% | $37.89 | $37.89 | $32.95 | 1,113,900 | |
| $38.17 | +1.24 | +3.4% | $37.41 | $38.73 | $35.51 | 865,500 | |
| $36.93 | -4.80 | -11.5% | $41.58 | $42.32 | $34.72 | 1,705,600 | |
| $41.73 | +0.85 | +2.1% | $41.01 | $42.49 | $39.41 | 9,086,000 | |
| $40.88 | +4.00 | +10.8% | $37.51 | $42.22 | $37.35 | 1,093,200 | |
| $36.88 | +1.16 | +3.2% | $36.19 | $38.92 | $35.37 | 971,000 | |
| $35.72 | -0.44 | -1.2% | $36.27 | $36.38 | $35.24 | 446,200 | |
| $36.16 | -0.72 | -2.0% | $37.06 | $37.58 | $35.60 | 482,300 | |
| $36.88 | +0.56 | +1.5% | $36.90 | $37.74 | $36.44 | 364,800 | |
| $36.32 | -2.44 | -6.3% | $38.76 | $38.77 | $36.13 | 680,800 | |
| $38.76 | -1.01 | -2.5% | $39.77 | $40.13 | $38.33 | 501,200 | |
| $39.77 | -0.65 | -1.6% | $40.97 | $41.05 | $39.07 | 564,000 | |
| $40.42 | -0.33 | -0.8% | $40.20 | $41.19 | $39.50 | 380,700 | |
| $40.75 | +0.64 | +1.6% | $40.21 | $40.83 | $39.12 | 408,300 | |
| $40.11 | +0.64 | +1.6% | $39.73 | $41.14 | $38.31 | 363,900 | |
| $39.47 | +0.46 | +1.2% | $39.15 | $40.00 | $37.88 | 500,200 | |
| $39.01 | -0.10 | -0.3% | $39.08 | $40.01 | $37.77 | 529,900 | |
| $39.11 | -0.18 | -0.5% | $38.96 | $40.02 | $38.50 | 316,200 | |
| $39.29 | +0.03 | +0.1% | $39.00 | $40.19 | $38.22 | 445,400 | |
| $39.26 | +0.03 | +0.1% | $39.17 | $39.41 | $38.09 | 409,100 | |
| $39.23 | +0.80 | +2.1% | $38.52 | $39.90 | $38.37 | 286,098 | |
| $38.43 | -0.93 | -2.4% | $39.42 | $40.56 | $38.00 | 340,272 | |
| $39.36 | -0.22 | -0.6% | $39.41 | $40.92 | $38.95 | 354,600 | |
| $39.58 | -1.74 | -4.2% | $40.70 | $41.49 | $39.31 | 205,800 | |
| $41.32 | +1.97 | +5.0% | $39.74 | $41.35 | $39.07 | 425,100 | |
| $39.35 | +2.13 | +5.7% | $37.18 | $39.81 | $35.60 | 639,000 | |
| $37.22 | +0.15 | +0.4% | $36.41 | $38.83 | $36.41 | 385,400 | |
| $37.07 | +1.40 | +3.9% | $35.67 | $37.99 | $34.78 | 290,900 | |
| $35.67 | -1.74 | -4.7% | $37.67 | $37.67 | $35.22 | 271,000 | |
| $37.41 | +0.94 | +2.6% | $36.11 | $37.83 | $36.01 | 217,300 | |
| $36.47 | +0.74 | +2.1% | $35.83 | $36.95 | $35.06 | 333,230 | |
| $35.73 | +0.75 | +2.1% | $35.44 | $36.93 | $34.93 | 397,748 | |
| $34.98 | -0.60 | -1.7% | $36.20 | $36.50 | $34.21 | 279,800 | |
| $35.58 | +0.68 | +1.9% | $35.10 | $36.50 | $34.13 | 263,700 | |
| $34.90 | -1.00 | -2.8% | $36.61 | $36.82 | $34.50 | 268,900 | |
| $35.90 | +1.94 | +5.7% | $34.03 | $36.69 | $33.23 | 357,100 | |
| $33.96 | -0.02 | -0.1% | $33.98 | $34.93 | $32.09 | 696,100 | |
| $33.98 | +1.70 | +5.3% | $32.44 | $34.18 | $31.50 | 355,900 | |
| $32.28 | +0.50 | +1.6% | $31.60 | $33.05 | $30.83 | 394,800 |
- Ticker
- NASDAQ:PBLS
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Oct 24, 2026
Parabilis Medicines Presents Updated Phase 1/2 Data for Zolucatetide Demonstrating Compelling Efficacy and Favorable Safety and Tolerability Profile in Patients with Desmoid Tumors
Latest deck · September 2026
Investor Presentation (September 2026)
Investor deck · 32 slides
Latest news
Parabilis Medicines Presents Updated Phase 1/2 Data for Zolucatetide Demonstrating Compelling Efficacy and Favorable Safety and Tolerability Profile in Patients with Desmoid Tumors
Oct 24, 2026
Closed $25.03 (+2.4%) on Oct 26, 2026
Parabilis Medicines to Present Updated Clinical Data for Zolucatetide in Patients with Desmoid Tumors at ESMO Congress 2026
Oct 19, 2026
Closed $25.35 (+11.4%) on Oct 19, 2026
Parabilis Medicines Initiates Dose-Ranging Clinical Study of Zolucatetide in Familial Adenomatous Polyposis
Oct 14, 2026
Closed $25.89 (-3.6%) on Oct 14, 2026
Parabilis Medicines to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference
Sep 1, 2026
Closed $39.47 (+1.2%) on Sep 1, 2026
Parabilis Medicines Appoints Accomplished Drug Development Leader Craig L. Tendler, M.D., to Board of Directors
Aug 25, 2026
Closed $39.23 (+2.1%) on Aug 25, 2026
Decks
Investor Presentation (September 2026)
Investor deck · 32 slides · September 2026
Earnings Presentation (August 2026)
Earnings · 32 slides · Aug 13, 2026
Technical Presentation (October 2025)
Technical · 17 slides · October 2025
Parabilis Medicines, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 6 in the last 12 months · 6 in all · newest Oct 24, 2026 · oldest 2026
- Decks
- 3 decks · latest September 2026
Where Parabilis Medicines, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:PBLS · Home listing · This page | NASDAQ | United States | USD |
| BOATS:PBLS | BOATS | United States | USD |
Log in to ask 6ix AI your own questions about Parabilis Medicines, Inc.